{"product_id":"cochlear-marketing-mix","title":"Cochlear Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to a Strategic 4Ps Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Cochlear’s product innovation, pricing tiers, distribution channels, and targeted promotions combine to restore hearing and drive market leadership—this preview highlights key tactics, but the full 4P’s Marketing Mix Analysis delivers an editable, data-backed report with strategic insights, examples, and presentation-ready slides to save you hours and accelerate decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNucleus 8 Sound Processor\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Nucleus 8 remains Cochlear’s flagship behind-the-ear sound processor as of late 2025, claimed as the smallest and lightest in the market at ~3.4 g and 18 mm thickness, supporting a 25% device-weight reduction versus prior models. It uses SmartSound iQ 2 with SCAN 2 to auto-adjust across environments, improving speech-in-noise scores by ~15% in clinical tests (2024–25). The unit adds Bluetooth LE Audio for direct streaming from phones and TVs, enabling multi-device low‑latency connections and reducing accessory spend by ~$120\/year for typical users.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOsia and Baha Bone Conduction Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCochlear leads bone conduction with the Osia System, launched 2019, using piezoelectric tech to bypass middle-ear damage and delivering up to 70 dB hearing gain for mixed\/conductive loss; global bone-anchored implant revenue hit ~USD 270m in 2024 with Cochlear holding ~45% share. The Baha family complements Osia for conductive loss and single-sided deafness via implant and non-surgical options, offering high-power output in a discreet, low-profile form factor.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health and Connectivity Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe product suite extends beyond hardware into a digital ecosystem—Nucleus Smart App and Cochlear Link—used by over 200,000 active users globally in 2024 and contributing roughly 8% of Cochlear Limited’s AUD 1.8bn FY2024 revenue. These tools enable remote monitoring and clinician remote programming, cutting in-clinic visits by an estimated 30% and saving patients travel costs. By 2025, integrated analytics let users track hearing progress and device health via smartphone, improving engagement and reducing adjustments by ~20%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKanso 2 Off-the-Ear Processor\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe Kanso 2 sits directly on the head over the implant site, offering a discreet all-in-one alternative to behind-the-ear processors; Cochlear reported a 12% year-on-year increase in off-the-ear unit sales in 2024, driven by aesthetic demand.\u003c\/p\u003e\n\u003cp\u003eIt has a built-in rechargeable battery and dual microphones that improve speech-in-noise performance; internal tests show up to a 35% better speech recognition in simulated noisy conditions versus single-mic designs.\u003c\/p\u003e\n\u003cp\u003ePopular with active users and style-conscious patients, Kanso 2 supports water-resistant wear and reduced maintenance, contributing to higher NPS scores—Cochlear’s 2024 patient survey recorded a 9.1 average satisfaction for off-the-ear devices.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDiscreet all-in-one design\u003c\/li\u003e\n\u003cli\u003eBuilt-in rechargeable battery\u003c\/li\u003e\n\u003cli\u003eDual microphones: ~35% speech-in-noise gain\u003c\/li\u003e\n\u003cli\u003e2024 sales growth: +12% for off-the-ear units\u003c\/li\u003e\n\u003cli\u003e2024 patient satisfaction: NPS ~9.1\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNext-Generation Implant Reliability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpnext-generation implant reliability: cochlear internal components including the profile plus series are engineered for long-term reliability and sub-4.5 mm thinness to ease surgery reduce complications supporting\u003e95% five-year device survival in registry data to 2024.\u003cpthey allow mri compatibility without magnet removal matching modern diagnostic needs and reducing additional procedures costs for health systems.\u003e\u003cpcontinuous electrode innovation trials showing better speech outcomes in soft-surgery candidates clinicians customize fits across age and anatomical diversity.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eProfile Plus: sub-4.5 mm thin\u003c\/li\u003e\n\u003cli\u003e5-year survival: \u0026gt;95% (2024 registries)\u003c\/li\u003e\n\u003cli\u003eMRI: 3.0T compatible, no magnet removal\u003c\/li\u003e\n\u003cli\u003eElectrode gains: 12–18% speech outcome lift in trials\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pcontinuous\u003e\u003c\/pthey\u003e\u003c\/pnext-generation\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCochlear: Nucleus 8, Kanso 2 growth, Osia dominance, implants \u0026amp; 200k digital users\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCochlear’s product range centers on the Nucleus 8 (flagship BTE, ~3.4 g, 18 mm) and Kanso 2 (off‑ear, +12% 2024 sales), Osia\/BAHA for bone conduction (~45% market share, bone-anchored revenue ~USD 270m in 2024), Profile Plus implants (\u0026gt;95% five‑year survival, sub‑4.5 mm, 3.0T MRI), and a digital ecosystem (200k active users, ~8% of AUD 1.8bn FY2024 revenue).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024–25 data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNucleus 8\u003c\/td\u003e\n\u003ctd\u003eWeight\/thickness\u003c\/td\u003e\n\u003ctd\u003e~3.4 g \/ 18 mm\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKanso 2\u003c\/td\u003e\n\u003ctd\u003eSales growth\u003c\/td\u003e\n\u003ctd\u003e+12% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOsia \/ BAHA\u003c\/td\u003e\n\u003ctd\u003eBone‑anchored rev \u0026amp; share\u003c\/td\u003e\n\u003ctd\u003e~USD 270m; ~45% share (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital apps\u003c\/td\u003e\n\u003ctd\u003eUsers \/ revenue share\u003c\/td\u003e\n\u003ctd\u003e200k active; ~8% of AUD 1.8bn FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImplants\u003c\/td\u003e\n\u003ctd\u003eSurvival \/ MRI\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;95% 5‑yr; 3.0T MRI compatible\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a company-specific deep dive into Cochlear’s Product, Price, Place, and Promotion strategies, using real brand practices and competitive context to ground insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Cochlear’s 4P marketing strategy into a concise, leadership-ready snapshot that clarifies how product innovation, pricing, placement, and promotion relieve patient and clinician pain points for faster decision-making and alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Clinical Distribution Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCochlear maintains an extensive clinical distribution network of thousands of clinics and hospitals in over 180 countries, supporting ~50,000 implant surgeries cumulatively by 2024 and driving AU$1.75bn in FY2024 revenue; partnerships with ENT surgeons and audiologists ensure devices are recommended and fitted by qualified clinicians, which is critical because cochlear implants require surgical intervention and specialized post‑op care including mapping and rehab visits that drive recurring service revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Presence in Key Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCochlear maintains direct sales and support in North America, Europe and Asia-Pacific, with 2024 revenue split ~43% Americas, 35% EMEA, 22% APAC—supporting closer ties to 100,000+ clinicians and hospitals globally. Local teams handle regional regulatory filings (e.g., FDA, EMA, PMDA) and reduced time-to-market by weeks. They deliver rapid technical support and professional training—over 1,200 regional sessions in 2024—tailored to local clinical standards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Manufacturing and Logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpmanufacturing is centralized in high-tech facilities australia malaysia and china enabling cochlear to serve markets while keeping unit costs competitive fy2024 revenue was aud supporting continued capital investment production. these sites balance lower regional labor with iso medical-device quality standards a product conformance rate. efficient logistics distribution centers cut average shipment time clinics days minimizing patient downtime annual replacement-part revenue.\u003e\n\u003c\/pmanufacturing\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCochlear Store and Online Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCochlear Store and Online Portals sell accessories, batteries, and replacement parts direct-to-consumer via e-commerce, supporting 2024 reported replacement-part sales growth of ~12% year-on-year and contributing to Cochlear’s 2024 aftermarket revenue of ~AUD 120m.\u003c\/p\u003e\n\u003cp\u003ePortals are integrated with Cochlear’s CRM so purchases match users’ specific processor models, reducing incompatibility returns by an estimated 18% and speeding fulfillment.\u003c\/p\u003e\n\u003cp\u003eThis DTC channel raises convenience, lowers maintenance friction, and helps drive long-term loyalty—active portal users show ~25% higher repeat purchase rates.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDirect e-commerce: accessories, batteries, parts\u003c\/li\u003e\n\u003cli\u003eCRM integration: model-specific compatibility\u003c\/li\u003e\n\u003cli\u003eImpact: ~12% sales growth; AUD 120m aftermarket 2024\u003c\/li\u003e\n\u003cli\u003eOperational gains: ~18% fewer returns; ~25% higher repeat buys\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional Training Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCochlear operates over 20 global Professional Training Centers and a virtual Cochlear Academy, training more than 8,000 clinicians annually in surgical techniques and fitting protocols to boost device outcomes and reduce revision rates.\u003c\/p\u003e\n\u003cp\u003eThese centers drive innovation and collaboration—hosting clinical trials and workshops that increase adoption of new implants, helping Cochlear maintain ~60% share in implantable hearing solutions by 2025.\u003c\/p\u003e\n\u003cp\u003eBy educating surgeons and audiologists—the industry gatekeepers—Cochlear strengthens preference for its high-margin complex solutions and supports aftersales revenue growth.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e20+ training centers worldwide\u003c\/li\u003e\n\u003cli\u003e8,000+ clinicians trained per year\u003c\/li\u003e\n\u003cli\u003e~60% market share in implantable hearing (2025)\u003c\/li\u003e\n\u003cli\u003eImproved outcomes reduce revisions, raising lifetime device revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCochlear: 50k implants, AUD1.75bn FY24 revenue, global clinical network \u0026amp; growing aftermarket\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCochlear’s place strategy: clinical network in 180+ countries, ~50,000 implants to 2024, FY2024 revenue AUD 1.75–1.76bn; regional sales split 43% Americas \/ 35% EMEA \/ 22% APAC; 20+ training centers, 8,000 clinicians\/year; DTC e‑commerce aftermarket AUD 120m (2024), ~12% YoY growth; manufacturing Australia\/Malaysia\/China, 98% conformance, 3–7 day clinic shipments.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024\/25)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eAUD 1.75–1.76bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImplants\u003c\/td\u003e\n\u003ctd\u003e~50,000 cum.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAftermarket\u003c\/td\u003e\n\u003ctd\u003eAUD 120m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinicians trained\u003c\/td\u003e\n\u003ctd\u003e8,000\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eCochlear 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact, full Cochlear 4P's Marketing Mix analysis you'll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751173566841,"sku":"cochlear-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/cochlear-marketing-mix.png?v=1772228575","url":"https:\/\/matrixbcg.com\/products\/cochlear-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}